Kingdon Capital Management, L.L.C. En V Veno Medical Corp Transaction History
Kingdon Capital Management, L.L.C.
- $834 Million
- Q3 2024
A detailed history of Kingdon Capital Management, L.L.C. transactions in En V Veno Medical Corp stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 859,261 shares of NVNO stock, worth $2.74 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
859,261
Previous 653,870
31.41%
Holding current value
$2.74 Million
Previous $3.43 Million
15.88%
% of portfolio
0.35%
Previous 0.4%
Shares
4 transactions
Others Institutions Holding NVNO
# of Institutions
42Shares Held
5.61MCall Options Held
89.3KPut Options Held
5.2K-
Perceptive Advisors LLC New York, NY694KShares$2.21 Million0.06% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT597KShares$1.9 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA589KShares$1.88 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL425KShares$1.36 Million0.01% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$1.28 Million3.48% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $30.2M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...